TNF and rheumatic disorder: Etanercept is a TNF-α antagonist that has already been developed and approved for the treatment of rheumatoid arthritis and several rheumatic diseases, and treatment with etanercept suppressed systemic inflammation and local inflammation in the brains of LPS-treated rats.